Menu
Recruiting NCT07552116

Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia

No phase Interventional Pneumonia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements, received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment..
Who it may be relevant to
Registry conditions: Pneumonia. Basic parameters: 3 years — 5 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Impact of Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia

Overview

Objective: The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, were included into ; group (A) received low intensity laser therapy, inspiratory muscle training in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.

Detailed description

The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, mean age of 3.73±1.82 year and were included into 2 equal groups; group (A) received low intensity laser therapy, inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.

Interventions

  • Other low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements
    low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements
  • Other received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
    received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.

Primary outcome measures

  • IgG [Time frame: at baseline and after one month]
  • IgA [Time frame: at baseline and after one month]
  • IgM [Time frame: at baseline and after one month]
  • WBCs [Time frame: at baseline and after one month]
Secondary outcome measures (2)
  • RR [Time frame: at baseline and after one month]
  • SaO2 [Time frame: at baseline and after one month]

Eligibility criteria

Inclusion criteria

  • Dawn Syndrome children with pneumonia
  • Mean age of 3.73±1.82 year
  • Children were in the first attack of bronchopneumonia.

Exclusion criteria

  • Other chest disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Mona Mohamed Abdelkhalek — Cairo

Identifiers

NCT: NCT07552116 · children with pneumonia

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗